- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 10 x SO4: SULFATE ION(Non-functional Binders)
- 4 x MRY: MESO-ERYTHRITOL(Non-covalent)
MRY.2: 5 residues within 4Å:- Chain A: Q.441, W.446, N.474, E.481, N.485
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:Q.441, A:W.446, A:N.474, A:N.474, A:N.485
MRY.7: 5 residues within 4Å:- Chain B: Q.441, W.446, N.474, E.481, N.485
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:Q.441, B:W.446, B:N.474, B:N.474, B:E.481, B:N.485
- Water bridges: B:Q.441
MRY.14: 5 residues within 4Å:- Chain C: Q.441, W.446, N.474, E.481, N.485
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:Q.441, C:N.474, C:N.474, C:E.481, C:N.485
MRY.19: 5 residues within 4Å:- Chain D: Q.441, W.446, N.474, E.481, N.485
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:Q.441, D:W.446, D:N.474, D:N.474, D:N.485
- 2 x 62F: [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{S})-5-[5-[(2~{R},3~{R},4~{S},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]-7,8-dimethyl-2,4-bis(oxidanyl)benzo[g]pteridin-10-yl]-2,3,4-tris(oxidanyl)pentyl] hydrogen phosphate(Non-covalent)
62F.3: 34 residues within 4Å:- Chain A: G.17, G.19, P.20, T.21, D.41, S.42, G.48, L.49, A.50, G.64, G.65, A.66, V.67, F.69, R.185, N.210, G.243, K.244, V.245, T.271, M.272, W.318, Y.329, R.330, E.376, G.421, Y.422, G.449, R.450, G.459, N.460, Q.461, S.464
- Ligands: UDP.4
26 PLIP interactions:26 interactions with chain A- Hydrophobic interactions: A:Y.422
- Hydrogen bonds: A:G.19, A:T.21, A:T.21, A:T.21, A:S.42, A:L.49, A:L.49, A:V.67, A:V.67, A:R.185, A:N.210, A:V.245, A:V.245, A:R.450, A:N.460, A:N.460, A:Q.461, A:Q.461, A:S.464
- Water bridges: A:G.22, A:T.271, A:R.450, A:F.451, A:F.451, A:N.460
62F.8: 35 residues within 4Å:- Chain B: G.17, G.19, P.20, T.21, D.41, S.42, G.48, L.49, A.50, V.63, G.64, G.65, A.66, V.67, F.69, R.185, N.210, G.243, K.244, V.245, T.271, M.272, W.318, Y.329, R.330, E.376, G.421, Y.422, G.449, R.450, G.459, N.460, Q.461, S.464
- Ligands: UDP.9
27 PLIP interactions:27 interactions with chain B- Hydrophobic interactions: B:Y.422
- Hydrogen bonds: B:G.19, B:T.21, B:T.21, B:T.21, B:S.42, B:L.49, B:L.49, B:V.67, B:V.67, B:R.185, B:N.210, B:V.245, B:V.245, B:R.450, B:N.460, B:N.460, B:Q.461, B:Q.461, B:D.462, B:S.464
- Water bridges: B:G.22, B:G.48, B:R.450, B:F.451, B:F.451, B:N.460
- 2 x UDP: URIDINE-5'-DIPHOSPHATE(Non-covalent)
UDP.4: 18 residues within 4Å:- Chain A: V.98, Y.107, F.109, Q.110, F.145, F.161, M.162, Y.165, N.166, V.169, W.170, R.185, V.186, Y.320, R.330, Y.422, Y.456
- Ligands: 62F.3
20 PLIP interactions:20 interactions with chain A- Hydrophobic interactions: A:Y.107, A:F.161
- Hydrogen bonds: A:F.109, A:Q.110, A:Q.110, A:Y.165, A:N.166, A:N.166, A:R.185, A:Y.320, A:Y.320, A:Y.456, A:Y.456
- Water bridges: A:A.187, A:A.187, A:N.210, A:N.210
- Salt bridges: A:R.330, A:R.330
- pi-Stacking: A:Y.320
UDP.9: 19 residues within 4Å:- Chain B: V.98, Y.107, P.108, F.109, Q.110, F.145, F.161, M.162, Y.165, N.166, V.169, W.170, R.185, V.186, Y.320, R.330, Y.422, Y.456
- Ligands: 62F.8
17 PLIP interactions:17 interactions with chain B- Hydrophobic interactions: B:Y.107, B:F.161
- Hydrogen bonds: B:F.109, B:Q.110, B:Q.110, B:N.166, B:N.166, B:R.185, B:Y.320, B:Y.422, B:Y.456
- Water bridges: B:R.185, B:Y.320, B:Y.320
- Salt bridges: B:R.330, B:R.330
- pi-Stacking: B:Y.320
- 2 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
FDA.15: 26 residues within 4Å:- Chain C: G.17, G.19, P.20, T.21, D.41, S.42, G.48, L.49, A.50, A.66, V.67, G.243, K.244, V.245, T.271, M.272, T.298, E.376, G.421, Y.422, G.449, R.450, G.459, N.460, Q.461, S.464
25 PLIP interactions:25 interactions with chain C- Hydrophobic interactions: C:L.49, C:T.298, C:Y.422
- Hydrogen bonds: C:G.19, C:T.21, C:T.21, C:T.21, C:S.42, C:L.49, C:L.49, C:A.66, C:V.67, C:V.67, C:V.245, C:V.245, C:R.450, C:N.460, C:Q.461, C:Q.461, C:S.464
- Water bridges: C:G.22, C:G.48, C:T.271, C:F.451, C:F.451
FDA.20: 27 residues within 4Å:- Chain D: G.17, G.19, P.20, T.21, D.41, S.42, G.48, L.49, A.50, V.63, A.66, V.67, G.243, K.244, V.245, T.271, M.272, T.298, E.376, G.421, Y.422, G.449, R.450, G.459, N.460, Q.461, S.464
25 PLIP interactions:25 interactions with chain D- Hydrophobic interactions: D:L.49, D:V.63, D:T.298, D:Y.422
- Hydrogen bonds: D:G.19, D:T.21, D:T.21, D:T.21, D:S.42, D:L.49, D:L.49, D:V.67, D:V.67, D:V.245, D:V.245, D:T.271, D:R.450, D:N.460, D:Q.461, D:Q.461, D:S.464
- Water bridges: D:G.22, D:F.451, D:F.451
- pi-Cation interactions: D:R.450
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mehra-Chaudhary, R. et al., In Crystallo Capture of a Covalent Intermediate in the UDP-Galactopyranose Mutase Reaction. Biochemistry (2016)
- Release Date
- 2016-02-17
- Peptides
- UDP-galactopyranose mutase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 10 x SO4: SULFATE ION(Non-functional Binders)
- 4 x MRY: MESO-ERYTHRITOL(Non-covalent)
- 2 x 62F: [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{S})-5-[5-[(2~{R},3~{R},4~{S},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]-7,8-dimethyl-2,4-bis(oxidanyl)benzo[g]pteridin-10-yl]-2,3,4-tris(oxidanyl)pentyl] hydrogen phosphate(Non-covalent)
- 2 x UDP: URIDINE-5'-DIPHOSPHATE(Non-covalent)
- 2 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mehra-Chaudhary, R. et al., In Crystallo Capture of a Covalent Intermediate in the UDP-Galactopyranose Mutase Reaction. Biochemistry (2016)
- Release Date
- 2016-02-17
- Peptides
- UDP-galactopyranose mutase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D